CELL BIOTECHNOLOGY GROUP INC.

Cell Treatment Research

Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study；
DateandTime：2022-06-27 13:21:27　|　Hits：227
Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus:

A Randomized Placebo-Controlled Study























©2022 CELL BIOTECHNOLOGY GROUP INC. All Rights Reserved　Tel：+1-647-4090807